Roeliene C. Kruizinga

1.4k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Roeliene C. Kruizinga is a scholar working on Oncology, Geriatrics and Gerontology and Physiology. According to data from OpenAlex, Roeliene C. Kruizinga has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Geriatrics and Gerontology and 4 papers in Physiology. Recurrent topics in Roeliene C. Kruizinga's work include Cancer, Hypoxia, and Metabolism (4 papers), Frailty in Older Adults (4 papers) and Nutrition and Health in Aging (4 papers). Roeliene C. Kruizinga is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Frailty in Older Adults (4 papers) and Nutrition and Health in Aging (4 papers). Roeliene C. Kruizinga collaborates with scholars based in Netherlands, Australia and Germany. Roeliene C. Kruizinga's co-authors include Annemiek Walenkamp, Elisabeth G.E. de Vries, Hetty Timmer‐Bosscha, Urszula Domańska, Wouter B. Nagengast, Gerwin Huls, Jeanine M. Van Ancum, Kira Scheerman, Carel G. M. Meskers and Andrea B. Maier and has published in prestigious journals such as Neurology, European Journal of Cancer and Current Pharmaceutical Design.

In The Last Decade

Roeliene C. Kruizinga

14 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review on CXCR4/CXCL12 axis in oncology: No place to hide

2012 510 citations Urszula Domańska, Roeliene C. Kruizinga et al. European Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roeliene C. Kruizinga Netherlands	13	555	322	253	193	174	14	1.1k
Seok‐Hyun Kim South Korea	16	262 0.5×	136 0.4×	386 1.5×	107 0.6×	118 0.7×	42	753
Ho Lee South Korea	21	533 1.0×	206 0.6×	517 2.0×	59 0.3×	164 0.9×	45	1.4k
Hyun Chang South Korea	21	552 1.0×	189 0.6×	360 1.4×	99 0.5×	253 1.5×	67	1.5k
Yoony Y. J. Gent Netherlands	12	119 0.2×	378 1.2×	220 0.9×	104 0.5×	52 0.3×	18	925
Jędrzej Grzegrzółka Poland	18	427 0.8×	140 0.4×	466 1.8×	100 0.5×	259 1.5×	76	1.1k
Kazuki Takakura Japan	21	414 0.7×	223 0.7×	336 1.3×	79 0.4×	115 0.7×	67	1.0k
Dong Lin China	14	186 0.3×	130 0.4×	263 1.0×	44 0.2×	195 1.1×	67	714
Kevin Li United States	9	394 0.7×	116 0.4×	627 2.5×	56 0.3×	122 0.7×	50	1.5k
Huayuan Zhu China	25	445 0.8×	307 1.0×	583 2.3×	56 0.3×	271 1.6×	137	1.6k
Silvia Giunco Italy	17	307 0.6×	121 0.4×	332 1.3×	222 1.2×	113 0.6×	37	880

Countries citing papers authored by Roeliene C. Kruizinga

Since Specialization

Citations

This map shows the geographic impact of Roeliene C. Kruizinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roeliene C. Kruizinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roeliene C. Kruizinga more than expected).

Fields of papers citing papers by Roeliene C. Kruizinga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roeliene C. Kruizinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roeliene C. Kruizinga. The network helps show where Roeliene C. Kruizinga may publish in the future.

Co-authorship network of co-authors of Roeliene C. Kruizinga

This figure shows the co-authorship network connecting the top 25 collaborators of Roeliene C. Kruizinga. A scholar is included among the top collaborators of Roeliene C. Kruizinga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roeliene C. Kruizinga. Roeliene C. Kruizinga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Meskers, Carel G. M., Esmee M. Reijnierse, Roeliene C. Kruizinga, et al.. (2019). Association of Handgrip Strength and Muscle Mass with Dependency in (Instrumental) Activities of Daily Living in Hospitalized Older Adults -The EMPOWER Study. The journal of nutrition health & aging. 23(3). 232–238. 43 indexed citations

Horst‐Schrivers, Anouk N.A. van der, Wim J. Sluiter, Roeliene C. Kruizinga, et al.. (2019). The incidence of consecutive manifestations in Von Hippel-Lindau disease. Familial Cancer. 18(3). 369–376. 14 indexed citations

Ancum, Jeanine M. Van, Kira Scheerman, Sjors Verlaan, et al.. (2017). Muscle Strength and Muscle Mass in Older Patients during Hospitalization: The EMPOWER Study. Gerontology. 63(6). 507–514. 30 indexed citations

Meskers, Carel G. M., Jeanine M. Van Ancum, Sjors Verlaan, et al.. (2017). High risk of malnutrition is associated with low muscle mass in older hospitalized patients - a prospective cohort study. BMC Geriatrics. 17(1). 118–118. 65 indexed citations

Ancum, Jeanine M. Van, Kira Scheerman, Nini H. Jonkman, et al.. (2017). Change in muscle strength and muscle mass in older hospitalized patients: A systematic review and meta-analysis. Experimental Gerontology. 92. 34–41. 83 indexed citations

Kruizinga, Roeliene C., Denise M.S. van Marion, Wilfred F.A. den Dunnen, et al.. (2016). Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma. Familial Cancer. 15(4). 607–616. 12 indexed citations

Kruizinga, Roeliene C., Wim J. Sluiter, Elisabeth G.E. de Vries, et al.. (2013). Calculating optimal surveillance for detection of von Hippel–Lindau-related manifestations. Endocrine Related Cancer. 21(1). 63–71. 38 indexed citations

Domańska, Urszula, Hetty Timmer‐Bosscha, Wouter B. Nagengast, et al.. (2012). CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy. Neoplasia. 14(8). 709–718. 156 indexed citations

Kruizinga, Roeliene C., Bernard A. Zonnenberg, Jacques W.M. Lenders, et al.. (2012). Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease. Neurology. 79(8). 793–796. 35 indexed citations

10.

Domańska, Urszula, Roeliene C. Kruizinga, Wouter B. Nagengast, et al.. (2012). A review on CXCR4/CXCL12 axis in oncology: No place to hide. European Journal of Cancer. 49(1). 219–230. 510 indexed citations breakdown →

11.

Kruizinga, Roeliene C., Hendrik J.M. de Jonge, Kim R. Kampen, Annemiek Walenkamp, & Eveline S.J.M. de Bont. (2010). Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemia. Pediatric Blood & Cancer. 56(2). 294–297. 8 indexed citations

12.

Domańska, Urszula, Roeliene C. Kruizinga, Wilfred F.A. den Dunnen, et al.. (2010). The chemokine network, a newly discovered target in high grade gliomas. Critical Reviews in Oncology/Hematology. 79(2). 154–163. 30 indexed citations

13.

Kruizinga, Roeliene C., Jovanka Bestebroer, Paul Berghuis, et al.. (2009). Role of Chemokines and Their Receptors in Cancer. Current Pharmaceutical Design. 15(29). 3396–3416. 50 indexed citations

14.

Stavenga, Doekele G., et al.. (1990). Dioptrics of the facet lenses of male blowflies Calliphora and Chrysomyia. Journal of Comparative Physiology A. 166(3). 365–71. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact